SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 74 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $11,423,179 | +22.2% | 556,414 | +41.7% | 0.00% | 0.0% |
Q1 2024 | $9,345,926 | -30.7% | 392,686 | -37.1% | 0.00% | -25.0% |
Q4 2023 | $13,484,856 | +435.5% | 624,010 | +259.8% | 0.00% | +300.0% |
Q3 2023 | $2,518,334 | -25.2% | 173,439 | +7.8% | 0.00% | 0.0% |
Q2 2023 | $3,368,621 | +105367.2% | 160,947 | +6.4% | 0.00% | 0.0% |
Q1 2023 | $3,194 | -13.3% | 151,237 | +4.4% | 0.00% | 0.0% |
Q4 2022 | $3,686 | -99.9% | 144,862 | -12.7% | 0.00% | -50.0% |
Q3 2022 | $3,986,000 | +24.9% | 165,877 | +0.0% | 0.00% | +100.0% |
Q2 2022 | $3,191,000 | +15.1% | 165,842 | +1.4% | 0.00% | 0.0% |
Q1 2022 | $2,773,000 | -5.4% | 163,590 | -0.2% | 0.00% | 0.0% |
Q4 2021 | $2,932,000 | -15.2% | 163,861 | -6.2% | 0.00% | 0.0% |
Q3 2021 | $3,458,000 | -7.2% | 174,670 | -19.5% | 0.00% | 0.0% |
Q2 2021 | $3,725,000 | +20.6% | 216,914 | +57.0% | 0.00% | 0.0% |
Q1 2021 | $3,090,000 | -11.1% | 138,191 | -11.6% | 0.00% | 0.0% |
Q4 2020 | $3,477,000 | +26.2% | 156,338 | -16.2% | 0.00% | 0.0% |
Q3 2020 | $2,755,000 | +58.4% | 186,641 | +59.1% | 0.00% | 0.0% |
Q2 2020 | $1,739,000 | +111.0% | 117,303 | +56.3% | 0.00% | – |
Q1 2020 | $824,000 | +5.2% | 75,037 | -15.8% | 0.00% | – |
Q4 2019 | $783,000 | -29.6% | 89,156 | -40.2% | 0.00% | – |
Q3 2019 | $1,113,000 | +9.4% | 148,988 | +36.4% | 0.00% | – |
Q2 2019 | $1,017,000 | – | 109,232 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,168,691 | $30,297,000 | 13.16% |
Boxer Capital, LLC | 234,220 | $3,272,000 | 0.78% |
SPHERA FUNDS MANAGEMENT LTD. | 296,310 | $4,139,000 | 0.70% |
Ghost Tree Capital, LLC | 200,000 | $2,794,000 | 0.58% |
Eventide Asset Management | 225,000 | $3,143,000 | 0.20% |
Vident Investment Advisory, LLC | 103,558 | $1,447,000 | 0.12% |
J. Goldman & Co LP | 147,181 | $2,056,000 | 0.11% |
TIVERTON ASSET MANAGEMENT LLC | 137,732 | $1,924,000 | 0.10% |
Crestline Management, LP | 55,368 | $773,000 | 0.10% |
Tekla Capital Management LLC | 200,000 | $2,794,000 | 0.10% |